Cyclacel Stock Market Sentiment

CYCC
 Stock
  

USD 0.81  0.03  3.57%   

Cyclacel investor sentiment overview provides quick insight into current market opportunities from investing in Cyclacel Pharmaceuti. The current market sentiment together Cyclacel Pharmaceuti's historical and current headlines can help investors to time the market. Many technical investors use Cyclacel Pharmaceuti stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Cyclacel Pharmaceuti Hype Analysis, Cyclacel Pharmaceuti Correlation and Cyclacel Pharmaceuti Performance.
  
Cyclacel Pharmaceuti stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Cyclacel daily returns and investor perception about the current pice of Cyclacel Pharmaceuti as well as its diversification or hedging effects on your existing portfolios.

Cyclacel Pharmaceuti Sentiment by Major News Outlets

Cyclacel Pharmaceuti Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Cyclacel Pharmaceuti has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Cyclacel Pharmaceuti's prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Cyclacel Pharmaceuti. Our Twitter sentiment analysis of Cyclacel Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
over two weeks ago at news.google.com         
Fierce Pharma AsiaGerman CEOs visit China Sanofi, Insilicos 1.2B pact Sumitomos job cuts - FiercePha...
news
over two weeks ago at news.google.com         
After nearly 20 years, Cyclacel kicks phase 3 leukemia drug back to Daiichi - FierceBiotech
news
over two weeks ago at news.google.com         
Transcript Cyclacel Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 09, 2022 - Marketscreener.com
news
over three weeks ago at news.google.com         
Cyclacel Pharmaceuticals to Release Third Quarter 2022 Financial Results - Marketscreener.com
news
over a month ago at news.google.com         
Abbotts FreeStyle Libre is Named Best Medical Technology in Last 50 Years by the Galien Foundation -...
news
over a month ago at news.google.com         
Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance - Investing News Network
news
over a month ago at investingnews.com         
Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus...
Investing News at Macroaxis
over two months ago at www.marketscreener.com         
CYCLACEL PHARMACEUTICALS, INC. Other Events - Marketscreener.com
Macroaxis News: marketscreener.com
over three months ago at www.macroaxis.com         
Acquisition by Gregory Hradsky of 2000 shares of Cyclacel Pharmaceuti subject to Rule 16b-3
Macroaxis News
over three months ago at www.investorsobserver.com         
Premarket Mover Cyclacel Pharmaceuticals Inc Up 2.49 percent - InvestorsObserver
Investors Business Daily at Macroaxis
over three months ago at news.google.com         
Cyclacel Pharmaceuticals Will Have To Spend Its Cash Wisely - Simply Wall St
news
over three months ago at www.investorsobserver.com         
Where Does Cyclacel Pharmaceuticals Inc Stock Fall in the Biotechnology Field After It Has Gained 31...
Investors Business Daily at Macroaxis
over three months ago at seekingalpha.com         
RIOT,MARA and CLSK are among pre market gainers - Seeking Alpha
seekingalpha News
over three months ago at www.globenewswire.com         
Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update ...
Macroaxis News: globenewswire.com
over three months ago at news.google.com         
Cyclacel Trading At Less Than Half Its Cash Value, Near-term Catalysts, No Bear Thesis - Seeking Alp...
news
Far too much social signal, news, headlines, and media speculation about Cyclacel Pharmaceuti that are available to investors today. That information is available publicly through Cyclacel media outlets and privately through word of mouth or via Cyclacel internal channels. However, regardless of the origin, that massive amount of Cyclacel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cyclacel Pharmaceuti news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cyclacel Pharmaceuti relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cyclacel Pharmaceuti's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cyclacel Pharmaceuti alpha.

Cyclacel Pharmaceuti Performance against DOW

 Price Growth (%)  
       Timeline  
1
CYCLACEL PHARMACEUTICALS, INC. Other Events - Marketscreener...09/13/2022
2
EPS Estimate09/30/2022
3
Abbotts FreeStyle Libre is Named Best Medical Technology in ...10/28/2022
4
EPS Reported11/09/2022
5
Fierce Pharma AsiaGerman CEOs visit China Sanofi, Insilicos ...11/11/2022
Continue to Cyclacel Pharmaceuti Hype Analysis, Cyclacel Pharmaceuti Correlation and Cyclacel Pharmaceuti Performance. Note that the Cyclacel Pharmaceuti information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuti price analysis, check to measure Cyclacel Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuti is operating at the current time. Most of Cyclacel Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuti's price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Cyclacel Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuti. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
10.5 M
Return On Assets
(0.42) 
Return On Equity
(0.60) 
The market value of Cyclacel Pharmaceuti is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuti's market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.